Clinical study for efficacy and safety of bone marrow derived cell concentrate and allogenic dermal matrix complex therapy in diabetic foot ulcer

Soon Chun Hyang University Hospital Bucheon0 个研究点目标入组 58 人开始时间: 待定最近更新: 2024年1月22日

适应症

试验速览

暂无简介。

•? Patients with intractable foot ulcers due to diabetes measuring between 2 x 2 cm² and less than 12 x 12 cm²
•? Patients with diabetic foot ulcers that do not heal for 3 weeks despite conventional conventional wound treatment
•? Patients with diabetic foot ulcers who have ABI <0.7 or who have undergone percutaneous angioplasty in cases where the wound exposes bone or tendon accompanied by infection.
•? Adults over 19 years old, under 70 years old
•? Those who signed the consent form after receiving an explanation of the purpose, methods, and effects of this study

•? Those who have been diagnosed with a malignant blood disease such as lymphoma or leukemia and have not experienced remission
•? People with severe anemia and other blood diseases
•? Those who have a history of solid cancer or have been diagnosed with solid cancer and are currently undergoing chemotherapy
•? Those who have undergone major surgical operations, organ biopsies, or significant trauma at the discretion of the researcher within 3 months prior to registration
•? Those with active infection
•? Those who are receiving or are scheduled to receive drugs that, as determined by the researcher, may affect the results
•? Persons who are unable to comply with the research plan and follow-up observations
•? Those who participated in another clinical trial within 30 days before registration
•? A person who is deemed inappropriate by the researcher to participate in this study.
•? Those currently taking steroids or immunosuppressants
•? Persons who did not sign the written consent form for this clinical study

发起方

Soon Chun Hyang University Hospital Bucheon